Correlation Between Astronics and Novocure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Astronics and Novocure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Astronics and Novocure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Astronics and Novocure, you can compare the effects of market volatilities on Astronics and Novocure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Astronics with a short position of Novocure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Astronics and Novocure.

Diversification Opportunities for Astronics and Novocure

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Astronics and Novocure is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Astronics and Novocure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novocure and Astronics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Astronics are associated (or correlated) with Novocure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novocure has no effect on the direction of Astronics i.e., Astronics and Novocure go up and down completely randomly.

Pair Corralation between Astronics and Novocure

Given the investment horizon of 90 days Astronics is expected to under-perform the Novocure. But the stock apears to be less risky and, when comparing its historical volatility, Astronics is 3.65 times less risky than Novocure. The stock trades about -0.04 of its potential returns per unit of risk. The Novocure is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest  1,648  in Novocure on September 20, 2024 and sell it today you would earn a total of  1,506  from holding Novocure or generate 91.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Astronics  vs.  Novocure

 Performance 
       Timeline  
Astronics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Astronics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Novocure 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Novocure are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak fundamental indicators, Novocure reported solid returns over the last few months and may actually be approaching a breakup point.

Astronics and Novocure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Astronics and Novocure

The main advantage of trading using opposite Astronics and Novocure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Astronics position performs unexpectedly, Novocure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novocure will offset losses from the drop in Novocure's long position.
The idea behind Astronics and Novocure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
CEOs Directory
Screen CEOs from public companies around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope